Position in TLRY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Derivatives in TLRY
reported options exposure · as of Mar 31, 2026CallValue
$1,378,110
CallShares
213,000
PutValue
$1,211,184
PutShares
187,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Walleye Trading LLC holds $96,751,076 across 12 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
672,924 | $79,546,346 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
499,536 | $15,046,024 | |
| 3 | VTRS |
Viatris Inc
|
50,756 | $685,713 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
19,000 | $454,670 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
1,697 | $223,562 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
9,046 | $187,794 | |
| 7 | PRGO |
PERRIGO Co plc
|
14,969 | $160,767 | |
| 8 | LQDA |
Liquidia Corp
|
4,049 | $152,809 |
All Filings in TLRY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,378,110 | 213,000 | Call | Sole | 2026-05-11 | |
| 2026-03-31 | $1,211,184 | 187,200 | Put | Sole | 2026-05-11 | |
| 2025-12-31 | $1,422,225 | 157,500 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $360,297 | 39,900 | Put | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||